BioCryst Pharmaceuticals
BCRX
#4613
Rank
A$3.45 B
Marketcap
A$13.53
Share price
-1.22%
Change (1 day)
6.82%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -A$0.65 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are A$0.88 Billion. In 2025 the company made an earning of A$0.37 Billion, an increase over its 2024 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.65 Billion-272.37%
2025 A$0.37 B-407.51%
2024 -A$0.13 Billion-61.56%
2023 -A$0.32 Billion-7.43%
2022 -A$0.35 Billion34.42%
2021 -A$0.26 Billion-0.55%
2020 -A$0.26 Billion67.88%
2019 -A$0.16 Billion7.55%
2018 -A$0.15 Billion53.92%
2017 -A$91.78 Million19.29%
2016 -A$76.94 Million28.19%
2015 -A$60.03 Million-4.8%
2014 -A$63.05 Million50.09%
2013 -A$42.01 Million-23.29%
2012 -A$54.77 Million-26.19%
2011 -A$74.2 Million54.78%
2010 -A$47.94 Million150.1%
2009 -A$19.17 Million-49.43%
2008 -A$37.9 Million14.07%
2007 -A$33.23 Million-49.31%
2006 -A$65.55 Million72.87%
2005 -A$37.92 Million22.08%
2004 -A$31.06 Million75.3%
2003 -A$17.72 Million-25.36%
2002 -A$23.74 Million225.05%
2001 -A$7.31 Million-56.6%
2000 -A$16.83 Million50.63%
1999 -A$11.18 Million38.05%
1998 -A$8.1 Million-52.46%
1997 -A$17.03 Million58.44%
1996 -A$10.75 Million-14.44%
1995 -A$12.56 Million28.57%
1994 -A$9.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$14.96 B-2,462.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.96 B-2,304.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$34.13 M-105.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.10 B-117.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$89.94 Million-85.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.44 Billion-31.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.29 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$30.97 Million-95.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$82.45 M-113.01%๐Ÿ‡บ๐Ÿ‡ธ USA